Assembly leader says lawmakers must focus on stopping the ‘real and immediate threat’ posed by Republican health care legislation in Washington D.C.
Such efforts have previously failed in the face of opposition from the drug industry, which questions their effectiveness and contends prices reflect research and development costs.
More than 30 states have laws on the books to allow dying patients the right-to-try experimental treatments. But these treatments may not be covered by insurance, and ethicists worry vulnerable people could be exploited near the end of their lives. The laws may also duplicate a process the FDA already has in place.